Ciwon Daji Na Mahaifa

Ciwon Daji Na Mahaifa
Description (en) Fassara
Iri female reproductive organ cancer (en) Fassara, ovarian neoplasm (en) Fassara, ovarian disease (en) Fassara, endocrine gland cancer (en) Fassara, rare genetic endocrine disease (en) Fassara, inherited gynecological tumor (en) Fassara
cuta
Field of study (en) Fassara oncology
Genetic association (en) Fassara BRIP1 (en) Fassara, ANKLE1 (en) Fassara, SKAP1 (en) Fassara, MUTYH (en) Fassara, BRIP1 (en) Fassara, RAD51C (en) Fassara da RAD51D (en) Fassara
Medical treatment (en) Fassara
Magani uracil mustard (en) Fassara, carboplatin (en) Fassara, paclitaxel (en) Fassara, vinorelbine (en) Fassara, docetaxel (en) Fassara, altretamine (en) Fassara, topotecan (en) Fassara, cisplatin (en) Fassara, (RS)-cyclophosphamide (en) Fassara, chlorambucil (en) Fassara, melphalan (en) Fassara, leuprolide (en) Fassara, doxorubicin (en) Fassara, ifosfamide (en) Fassara, hydroxycarbamide (en) Fassara, chromic phosphate p-32 (en) Fassara, niraparib (en) Fassara, olaparib (en) Fassara, cisplatin (en) Fassara, (RS)-cyclophosphamide (en) Fassara da belotecan (en) Fassara
Identifier (en) Fassara
ICD-10-CM C56
ICD-9-CM 183.0
ICD-O: VARIED
OMIM 167000 da 607893
DiseasesDB 9418
MedlinePlus 000889
eMedicine 000889
Disease Ontology ID DOID:2394

Ciwon daji na Ovarian ciwon daji ne wanda ke samuwa a ciki ko akan kwai .[1][2] Yana haifar da ƙananan ƙwayoyin cuta waɗanda ke da ikon mamayewa ko yada zuwa wasu sassan jiki.[3] Lokacin da wannan tsari ya fara, ba za a iya samun bayyanar cututtuka ba ko kawai.[4] Alamun suna zama ana gani yayin da ciwon daji ke ci gaba.[5][6] Wadannan bayyanar cututtuka na iya haɗawa da kumburi, zafi na pelvic, kumburi na ciki, maƙarƙashiya, da asarar ci, da sauransu.[7] Wuraren gama gari waɗanda ciwon daji zai iya yaɗuwa sun haɗa da rufin ciki, ƙwayoyin lymph, huhu, da hanta .[8]

Hadarin ciwon daji na kwai yana karuwa a cikin matan da suka fi yin kwai a tsawon rayuwarsu. Wannan ya kuma haɗa da waɗanda ba su taɓa haihuwa ba, waɗanda suka fara ovulation tun suna ƙanana da waɗanda suka kai ga al'ada tun lokacin da suka tsufa.[7] Sauran abubuwan haɗari sun haɗa da maganin hormone bayan menopause, maganin haihuwa, da kuma kiba [9][1] Abubuwan da ke rage haɗari sun haɗa da maganin hana haihuwa na hormonal, ƙwayar tubal, da shayarwa .[9] Kimanin kashi 10% na lokuta suna da alaƙa da haɗarin gadon gado; Mata masu maye gurbi a cikin kwayoyin halitta BRCA1 ko BRCA2 suna da kusan kashi 50% na damar kamuwa da cutar.[7] Ciwon daji na Ovarian shine nau'in ciwon daji na ovarian da aka fi sani, wanda ya ƙunshi fiye da kashi 95% na lokuta.[7] Akwai manyan nau'o'in nau'in ciwon daji na ovarian guda biyar, waɗanda carcinoma mai girma mai daraja (HGSC) ya fi yawa.[7] Wadannan ciwace-ciwacen ovarian an yi imanin suna farawa a cikin sel da ke rufe kwai, [10] ko da yake wasu na iya samuwa a cikin tubes na Fallopian . [11] Mafi qarancin nau'ikan ciwon daji na kwai sun haɗa da ciwace-ciwacen ƙwayoyin cuta[7] da ciwace-ciwacen jima'i . Ana tabbatar da ganewar cutar kansar kwai ta hanyar biopsy na nama, yawanci ana cirewa yayin tiyata. [4]

Ba a ba da shawarar dubawa a cikin matan da ke cikin matsakaicin haɗari ba, kamar yadda shaida ba ta goyi bayan raguwar mutuwa ba kuma yawan adadin gwaje-gwajen ƙarya na iya haifar da tiyata maras buƙata, wanda ke tare da haɗarinsa. Wadanda ke cikin hatsarin gaske na iya cire ovaries a matsayin ma'aunin rigakafi. [12] Idan an kama shi kuma a bi da shi a farkon mataki, ciwon daji na ovarian sau da yawa ana iya warkewa. [1] Jiyya yawanci ya haɗa da wasu haɗin tiyata, maganin radiation, da chemotherapy . [4] Sakamakon ya dogara da girman cutar, nau'in ciwon daji da ke da shi, da sauran yanayin kiwon lafiya.[7][13] Jimillar adadin tsira na shekaru biyar a Amurka shine kashi 49%.[14] Sakamakon ya fi muni a ƙasashe masu tasowa. [7]

A cikin 2012, sabbin maganganu sun faru a cikin kusan mata 239,000.[7] A cikin 2015 ya kasance a cikin mata miliyan 1.2 kuma ya haifar da mutuwar 161,100 a duniya.[15][16] A cikin mata shi ne na bakwai-mafi yawan kamuwa da cutar kansa kuma na takwas-mafi yawan sanadin mutuwar cutar kansa.[7] Yawan shekarun ganewar asali shine 63. Mutuwa daga ciwon daji na kwai ya fi yawa a Arewacin Amurka da Turai fiye da Afirka da Asiya. [7]

  1. 1.0 1.1 1.2 "Ovarian Cancer Prevention". NCI. December 6, 2013. Archived from the original on 6 July 2014. Retrieved 1 July 2014.
  2. Seiden, Michael (2015). "Gynecologic Malignancies, Chapter 117". MGraw-Hill Medical. Archived from the original on September 10, 2017. Retrieved June 24, 2017.
  3. "Defining Cancer". National Cancer Institute. 2007-09-17. Archived from the original on 25 June 2014. Retrieved 10 June 2014.
  4. 4.0 4.1 4.2 "Ovarian Epithelial Cancer Treatment". NCI. 2014-05-12. Archived from the original on 5 July 2014. Retrieved 1 July 2014.
  5. "Ovarian Epithelial Cancer Treatment". NCI. 2014-05-12. Archived from the original on 5 July 2014. Retrieved 1 July 2014.
  6. Ebell MH, Culp MB, Radke TJ (March 2016). "A Systematic Review of Symptoms for the Diagnosis of Ovarian Cancer". American Journal of Preventive Medicine. 50 (3): 384–394. doi:10.1016/j.amepre.2015.09.023. PMID 26541098.
  7. 7.00 7.01 7.02 7.03 7.04 7.05 7.06 7.07 7.08 7.09 7.10 "Ovarian Epithelial Cancer Treatment". NCI. 2014-05-12. Archived from the original on 5 July 2014. Retrieved 1 July 2014.
  8. Ruddon RW (2007). Cancer Biology (4th ed.). Oxford: Oxford University Press. p. 223. ISBN 9780195175431. Archived from the original on 2015-09-15.
  9. 9.0 9.1 Ruddon RW (2007). Cancer Biology (4th ed.). Oxford: Oxford University Press. p. 223. ISBN 9780195175431. Archived from the original on 2015-09-15.
  10. Piek JM, van Diest PJ, Verheijen RH (2008). "Ovarian carcinogenesis: an alternative hypothesis". Ovarian Cancer. Adv. Exp. Med. Biol. Advances in Experimental Medicine and Biology. 622. pp. 79–87. doi:10.1007/978-0-387-68969-2_7. ISBN 978-0-387-68966-1. PMID 18546620.Samfuri:Closed access
  11. Maoz, Asaf; Matsuo, Koji; Ciccone, Marcia A.; Matsuzaki, Shinya; Klar, Maximilian; Roman, Lynda D.; Sood, Anil K.; Gershenson, David M. (2020-05-29). "Molecular Pathways and Targeted Therapies for Malignant Ovarian Germ Cell Tumors and Sex Cord-Stromal Tumors: A Contemporary Review". Cancers. 12 (6): 1398. doi:10.3390/cancers12061398. ISSN 2072-6694. PMC 7353025. PMID 32485873.
  12. Grossman DC, Curry SJ, Owens DK, Barry MJ, Davidson KW, Doubeni CA, et al. (February 2018). "Screening for Ovarian Cancer: US Preventive Services Task Force Recommendation Statement". JAMA. 319 (6): 588–594. doi:10.1001/jama.2017.21926. PMID 29450531.
  13. Gibson SJ, Fleming GF, Temkin SM, Chase DM (2016). "The Application and Outcome of Standard of Care Treatment in Elderly Women with Ovarian Cancer: A Literature Review over the Last 10 Years". Frontiers in Oncology. 6: 63. doi:10.3389/fonc.2016.00063. PMC 4805611. PMID 27047797.
  14. "SEER Stat Fact Sheets: Ovary Cancer". NCI. Archived from the original on 6 July 2014. Retrieved 18 June 2014.
  15. GBD 2015 Mortality and Causes of Death Collaborators (October 2016). "Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1459–1544. doi:10.1016/S0140-6736(16)31012-1. PMC 5388903. PMID 27733281.
  16. GBD 2015 Disease and Injury Incidence and Prevalence Collaborators (October 2016). "Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet. 388 (10053): 1545–1602. doi:10.1016/S0140-6736(16)31678-6. PMC 5055577. PMID 27733282.

From Wikipedia, the free encyclopedia · View on Wikipedia

Developed by Nelliwinne